Nav: Home

Direct-to-consumer genomics: Harmful or empowering?

February 23, 2017

ST. LOUIS -- Thanks to recent scientific advances and plunging costs in genetic sequencing, consumers now can order simple, inexpensive, mail-in genetic tests to learn more about health risks, inherited traits and ancestry. But, is it a good idea to bypass your doctor's office when it comes to interpreting health risks?

New technology means grappling with new questions of ethics, best practices and access to information. In an article published in Missouri Medicine, Joel Eissenberg, Ph.D., professor of biochemistry and molecular biology at Saint Louis University, explores questions that stem from these advances, which have the effect of separating the physician-patient relationship from access to new personal health data.

Some companies offer DNA tests via a mail-in saliva sample. Once the sample is tested, the company provides consumers with a report showing whether they are a carrier for any of over 35 diseases, as well as information about traits and ancestry. Participants might learn, for example, that they carry a genetic variation for cystic fibrosis or hereditary hearing loss. Carriers may pass along these genetic variations to a child, who could develop the condition if both parents carry and pass on the variation.

Other tests might find that a consumer carries a genetic variation that increases the risk of breast cancer or Alzheimer's disease. In the case of breast cancer, preventive measures, like regular screening via mammography or preventive surgery, may offer a chance to limit the risk of developing cancer. On the other hand, there is no proven medical treatment for Alzheimer's disease.

In the article, Eissenberg notes several areas of concern for consumers as they attempt to interpret their personal information without the help of a physician or genetic counselor, including a limited understanding of genetics, confusion about disease risk and anxiety caused by new information in the absence of guidance from a medical professional.

Eissenberg concludes, however, that individuals should be able to access their own personal genome data.

"In an open society, maximizing autonomy is a virtue," Eissenberg said. "Knowledge is power."

He notes that, in many ways, we've already moved along the path of patient-initiated testing, with digital thermometers, blood pressure cuffs, blood sugar monitors and pregnancy testing kits that give the public direct access to health information.

In theory, understanding genetic risk could help guide life decisions, such as encouraging regular cancer screenings, a healthy diet and exercise to offset some genetic risks for some illnesses. (Though, some research has found that communicating DNA-based disease risk has little or no effect on smoking and physical activity.)

"At its best, direct-to-consumer genomics testing could eventually become like other forms of home medical testing - another way for people to take personal control of their health and wellness," Eissenberg said.

At the same time, he urges caution in how these tests are marketed, noting that currently they are not able to offer useful predictions or recommendations for many diseases.

"Today, however, genomics testing to assess risk for complex diseases rests on a weak foundation of clinical validation. Thus, in most cases, genomics data cannot serve as a guide to action."

Finally, while Eissenberg does not believe medical paternalism is warranted in restricting access to direct-to-consumer tests, he shares several instances in which consumers may benefit from consulting with their physician or a genetic counselor: to prepare for adverse news, to help interpret risk, to prescribe a risk response and to counsel caution in over interpretation.

But the bottom line?

"It is important to stress that genetic risk is not the same as genetic destiny," Eissenberg said.
-end-
Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious diseases.

Saint Louis University

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...